2015 ICD-9-CM Diagnosis Code 238.79
Other lymphatic and hematopoietic tissues
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 238.79 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 238.79 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
238.79 converts approximately to:
- 2015/16 ICD-10-CM C94.40 Acute panmyelosis with myelofibrosis not having achieved remission
Or:
- 2015/16 ICD-10-CM C94.41 Acute panmyelosis with myelofibrosis, in remission
Or:
- 2015/16 ICD-10-CM C94.42 Acute panmyelosis with myelofibrosis, in relapse
Or:
- 2015/16 ICD-10-CM D47.1 Chronic myeloproliferative disease
Or:
- 2015/16 ICD-10-CM D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
Or:
- 2015/16 ICD-10-CM D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Approximate Synonyms
- Acute myelofibrosis (disorder)
- Acute myelofibrosis in relapse
- Acute myelofibrosis in remission
- Acute panmyelosis w myelofibrosis
- Acute panmyelosis w myelofibrosis, in relapse
- Acute panmyelosis w myelofibrosis, in remission
- Acute panmyelosis with myelofibrosis
- Atypical lymphoproliferative disorder
- Chronic myeloproliferative disorder
- Chronic myeloproliferative disorder (clinical)
- Extramedullary megakaryocytopoiesis
- Familial hemophagocytic lymphohistiocytosis
- Fatal infectious mononucleosis associated with X-linked lymphoproliferative syndrome
- Fungating tumor of lymph node
- Hematologic neoplasm of uncertain behavior
- Hemolytic anemia associated with lymphoproliferative disorder
- Hemolytic anemia w lymphoproliferative disease
- Hemolytic anemia, lymphoproliferative disease
- Lymphocytic hypoplasia
- Lymphoproliferative disorder
- Mast cell neoplasm
- Myeloproliferative disorder
- Myeloproliferative disorder, chronic
- Neoplasm affecting hematopoietic structure
- Neoplasm of bone marrow
- Neoplasm of hematopoietic cell type
- Neoplasm of uncertain behavior of lymphatic or hematopoietic system
- Neoplasm of uncertain behavior, lymphatic or hematopoietic
- Neoplasm uncert behav lymphatic or hematopoietic
- Post-transplant lymphoproliferative disorder
- Thrombophilia due to myeloproliferative disorder
- Virus-associated atypical lymphoproliferative disorder
- X-linked lymphoproliferative syndrome
Clinical Information
- An acute myeloid leukemia characterized by bone marrow fibrosis. The prognosis is usually poor. (who, 2001)
- Chronic myeloproliferative disorders (cmpds) are clonal hematopoietic stem cell disorders, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, and megakaryocytic) lineages. The proliferation is associated with relatively normal, effective maturation, resulting in increased numbers of granulocytes, red blood cells, and/or platelets in the peripheral blood. Cmpds are primarily diseases of adults
Applies To
- Lymphoproliferative disease (chronic) NOS
- Megakaryocytic myelosclerosis
- Myeloproliferative disease (chronic) NOS
- Panmyelosis (acute)
lymphoproliferative (chronic) (M9970/1) 238.79
X linked 759.89
